corona-5174671_640
14. May 2021 | News

AIPPI Position Paper: TRIPS Agreement and the COVID-19 Waiver

 

Logo

We are pleased to inform you that AIPPI's Standing Committees on TRIPS and Pharma have prepared a Bureau approved position paper on the waiver for certain provisions of the TRIPS agreement for the prevention, containment and treatment of COVID-19 proposed by some countries within the WTO. 

 

From the position paper:

"AIPPI shares the concerns raised by the waiver proponents and co-sponsors, and echoed by other WTO members, international organisations, and the public opinion with respect to the challenges posed by the current pandemic to a plurality of aspects of the world’s society and economy".

"Moreover, our Association applauds the calls for an active commitment to a comprehensive, global approach that leverages the entire multilateral trading system in place to support the research, development, manufacturing, and distribution of safe and effective COVID-19 diagnostics, equipment, therapeutics, and vaccines".

"AIPPI is not aware of evidence that intellectual property rights constitute a barrier for accessibility of COVID-19 related medicines and technologies. In the opinion of AIPPI, waiving TRIPS provisions would negatively impact the framework established to reach the objectives mentioned above on both a medium and a long-term basis. AIPPI also urges WTO members to recognize how intellectual property rights have contributed to the advancement of science and to innovations in medicine and public health. The recently developed COVID-19 vaccines and therapeutics were discovered based on years of research supported by intellectual property rights".

"AIPPI believes that the execution, the implementation and the consequent effects of a waiver in various legal systems should be appropriately assessed before any change or waiver is effected". 

"We trust that the discussions being held at the WTO TRIPS Council will (1) find an appropriate global approach to contribute to solving the problems posed by the current pandemic, while (2) balancing the right of all to have access to health services and supplies with other stakeholders’ rights and (3) safeguarding, with a long-term view, the system that has proven effective in nurturing innovation and enabled the world to achieve a stage of technological development advanced enough successfully to develop, produce and deploy multiple state-of-the-art responses to pressing global challenges in record time, as we all have recently witnessed".

Read the position paper in full here.